<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Colorectal Cancer - Okell Surgery Notes</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="12-cleft-lip-and-palate.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 21.6%;"></div>
                        </div>
                       <span class="progress-text">Topic 13 of 60</span>
                    </div>
                    <a href="14-pyloric-stenosis.html" class="nav-button">
                        <span class="nav-text">Next: Pyloric Stenosis</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">COLORECTAL CANCER</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: introduction -->
                <section id="introduction" class="content-section">
                    <div class="content-card">
                        <h3>Introduction</h3>
                        <ul class="enhanced-list">
                            <li>Ninety percent of colorectal cancers occur in patients over 50 years of age.</li>
                            <li>Adenomas precede carcinomas.</li>
                            <li>Early cancers are asymptomatic.</li>
                            <li>Fecal occult blood testing can detect preneoplastic lesions and early cancers.</li>
                            <li>Microcytic anemia in the elderly suggests the presence of colorectal cancer.</li>
                            <li>Hematochezia may be a sign of colorectal cancer (especially of the distal colon and rectum).</li>
                            <li>Weight loss and obstructive symptoms are late findings.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: introduction -->

                <!-- START: diagnosis -->
                <section id="diagnosis" class="content-section">
                    <h2 class="section-heading">Diagnosis & Clinical Presentation</h2>
                    <div class="content-card">
                        <h3>History - Symptoms</h3>
                        <ol class="enhanced-list">
                            <li><strong>Per rectal Bleeding:</strong> Most common symptom of rectal cancer (60%). Higher tumors may present with occult bleeding. Bleeding mixed with stool, usually no heavy bleeding. May be mucoid.</li>
                            <li><strong>Change in bowel habit:</strong> Often diarrhea (especially if large villous component), or alternating constipation and diarrhea.</li>
                            <li><strong>Incomplete evacuation:</strong> Tumors low in rectum cause tenesmus.</li>
                            <li><strong>Abdominal pain:</strong> Colicky pain and bloating from partial obstruction.</li>
                            <li><strong>Back pain:</strong> Late sign (nerve invasion/compression).</li>
                            <li><strong>Urinary symptoms:</strong> Invasion of bladder or prostate.</li>
                            <li><strong>Constitutional signs:</strong> Malaise, weight loss, night sweat, anorexia.</li>
                            <li><strong>Bowel obstruction:</strong> Complete obstruction of large bowel is rare.</li>
                            <li><strong>Emergencies:</strong> Peritonitis from perforation (3%) or jaundice from liver metastases (<1%).</li>
                        </ol>

                        <h3>Predisposing Factors</h3>
                        <ol class="enhanced-list">
                            <li><strong>Diet:</strong> Fatty diet. High-fiber, calcium, selenium, vitamins A, C, E are protective.</li>
                            <li><strong>Alcohol:</strong> Daily drinkers have 2-fold increased risk.</li>
                            <li><strong>Cigarette smoking</strong></li>
                            <li><strong>Pelvic radiation</strong></li>
                            <li><strong>Inflammatory bowel disease (IBD):</strong>
                                <ul>
                                    <li><strong>Ulcerative colitis:</strong> Incidence increases with duration. Dysplasia is precursor.</li>
                                    <li><strong>Crohn disease:</strong> 4-20 times greater risk. Cancers often develop in strictures/fistulas.</li>
                                </ul>
                            </li>
                            <li><strong>Genetic predispositions:</strong>
                                <ul>
                                    <li><strong>Hereditary nonpolyposis colorectal cancer (HNPCC):</strong> Defective mismatch repair genes (Chr 2, 3, 7).</li>
                                    <li><strong>Familial adenomatous polyposis coli (FAP):</strong> Defect in <em>APC</em> gene (Chr 5). Hundreds of polyps, osteomas, desmoid tumors. 100% cancer risk by age 40 if untreated.</li>
                                </ul>
                            </li>
                        </ol>
                    </div>
                </section>
                <!-- END: diagnosis -->

                <!-- START: pathology -->
                <section id="pathology" class="content-section">
                    <h2 class="section-heading">Pathology & Spread</h2>
                    <div class="content-card">
                        <h3>Gross Morphology</h3>
                        <ul class="enhanced-list">
                            <li><strong>Cauliflower:</strong> Least malignant form.</li>
                            <li><strong>Annular:</strong> Tends to cause obstructive symptoms.</li>
                            <li><strong>Ulcerative:</strong> Commonly presents with bleeding.</li>
                            <li><strong>Tubular</strong></li>
                        </ul>

                        <h3>Histology</h3>
                        <p>Mostly <strong>Adenocarcinomas</strong> (well or poorly differentiated glandular structures).<br>
                        Normal topological architecture (crypt-villous axis) is lost.<br>
                        Anorectal lesions have a squamous morphology.</p>

                        <h3>Spread</h3>
                        <ol class="enhanced-list">
                            <li><strong>Local spread:</strong> Submucosal infiltration.</li>
                            <li><strong>Lymphatic spread (90%):</strong>
                                <ul>
                                    <li>N1: Epicolic nodes (immediate vicinity of bowel wall).</li>
                                    <li>N2: Paracolic nodes (along colic arteries).</li>
                                    <li>N3: Apical nodes (around superior/inferior mesenteric vessels) → Virchow's node (Left supraclavicular).</li>
                                </ul>
                            </li>
                            <li><strong>Haematogenous (10%):</strong> Liver (portal system), Lung, Bone.</li>
                            <li><strong>Transcoelomic</strong></li>
                            <li><strong>Iatrogenic</strong></li>
                        </ol>
                    </div>
                </section>
                <!-- END: pathology -->

                <!-- START: investigations -->
                <section id="investigations" class="content-section">
                    <h2 class="section-heading">Investigations</h2>
                    <div class="content-card">
                        <h3>Lab Studies</h3>
                        <ul class="enhanced-list">
                            <li><strong>CBC:</strong> Anaemia (microcytic).</li>
                            <li><strong>LFT and U/E/C:</strong> Liver function tests often normal even with metastases.</li>
                            <li><strong>CEA (Carcinoembryonic antigen):</strong> Baseline and follow-up. >100 ng/mL usually indicates metastasis.</li>
                        </ul>

                        <h3>Imaging</h3>
                        <ol class="enhanced-list">
                            <li><strong>Proctosigmoidoscopy/Colonoscopy & Biopsy:</strong> Direct visualization, size estimation, biopsy. Distance from dentate line is critical for surgical decision.</li>
                            <li><strong>Double contrast barium enema:</strong> 'Apple core' appearance (short, irregular stenosis with sharp shoulders).</li>
                            <li><strong>Endorectal ultrasound (ERUS):</strong> Assesses depth of invasion and lymph node involvement.</li>
                            <li><strong>Metastatic workup:</strong>
                                <ul>
                                    <li>Abdominal pelvic ultrasound (liver, bladder, other organs).</li>
                                    <li>Chest radiograph (pulmonary metastases).</li>
                                    <li>CT scan (liver, adrenals, ovaries, lymph nodes).</li>
                                    <li>MRI (most sensitive for liver metastases).</li>
                                </ul>
                            </li>
                        </ol>
                    </div>
                </section>
                <!-- END: investigations -->

                <!-- START: staging -->
                <section id="staging" class="content-section">
                    <h2 class="section-heading">Staging</h2>
                    <div class="content-card">
                        <h3>Dukes Staging (Modified by Astler-Coller)</h3>
                        <div class="table-container">
                            <table>
                                <tr><td><strong>Stage A</strong></td><td>Limited to rectal mucosa</td></tr>
                                <tr><td><strong>Stage B1</strong></td><td>Extend into muscularis propria</td></tr>
                                <tr><td><strong>Stage B2</strong></td><td>Extend through muscularis propria</td></tr>
                                <tr><td><strong>Stage C1</strong></td><td>B1 plus nodal involvement</td></tr>
                                <tr><td><strong>Stage C2</strong></td><td>B2 plus nodal involvement</td></tr>
                                <tr><td><strong>Stage D</strong></td><td>Distant metastasis</td></tr>
                            </table>
                        </div>

                        <h3>TNM Classification (AJCC)</h3>
                        <p><strong>Primary Tumor (T)</strong></p>
                        <ul>
                            <li>Tis: Carcinoma in situ</li>
                            <li>T1: Invades lamina propria</li>
                            <li>T2: Invades muscularis propria</li>
                            <li>T3: Invades through muscularis propria into subserosa/pericolic tissue</li>
                            <li>T4: Perforates visceral peritoneum or invades other organs</li>
                        </ul>
                        <p><strong>Regional Lymph Nodes (N)</strong></p>
                        <ul>
                            <li>N0: No metastasis</li>
                            <li>N1: 1-3 nodes</li>
                            <li>N2: 4 or more nodes</li>
                            <li>N3: Nodes along named vascular trunk</li>
                        </ul>
                        <p><strong>Distant Metastasis (M)</strong></p>
                        <ul>
                            <li>M0: No distant metastasis</li>
                            <li>M1: Distant metastasis</li>
                        </ul>
                    </div>
                </section>
                <!-- END: staging -->

                <!-- START: management -->
                <section id="management" class="content-section">
                    <h2 class="section-heading">MANAGEMENT</h2>
                    <div class="content-card">
                        <h3>Treatment of Polyps</h3>
                        <p>10% of polyps > 1 cm contain carcinoma. Pedunculated polyps may be removed colonoscopically if criteria met (differentiation, margins clear). Sessile polyps with cancer require resection.</p>

                        <h3>Surgical Management</h3>
                        
                        <h4>Rectal Cancer Surgery</h4>
                        <ol class="enhanced-list">
                            <li><strong>Low Anterior Resection (LAR):</strong> For lesions in middle/upper third (sometimes lower). Lesion > 8 cm from dentate line. Uses Total Mesorectal Excision (TME).</li>
                            <li><strong>Abdominoperineal Resection (APR):</strong> For lower-third cancers where sphincter cannot be spared. Creates permanent end-sigmoid colostomy.</li>
                        </ol>

                        <h4>Colon Cancer Surgery</h4>
                        <ul class="enhanced-list">
                            <li><strong>Right Hemicolectomy:</strong> Caecal, ascending, or proximal transverse colon tumours.</li>
                            <li><strong>Left Hemicolectomy:</strong> Distal transverse or descending colon tumours.</li>
                            <li><strong>Transverse Colectomy:</strong> For transverse colon tumours.</li>
                            <li><strong>Sigmoid Colectomy:</strong> For sigmoid colon tumours.</li>
                        </ul>

                        <h4>Inoperable Tumour with Obstruction</h4>
                        <ul>
                            <li>Ascending colon: Bypass (ileocolic anastomosis).</li>
                            <li>Left colon: Transverse colostomy.</li>
                            <li>Pelvic colon: Left iliac fossa colostomy.</li>
                        </ul>

                        <h3>Adjuvant Therapy</h3>
                        <ul class="enhanced-list">
                            <li><strong>Radiotherapy:</strong> Preoperative (down-staging) or Postoperative (decreases local recurrence).</li>
                            <li><strong>Chemotherapy:</strong> 5-fluorouracil with levamisole. Irinotecan, methyl-CCNU.</li>
                        </ul>

                        <h3>Prevention & Screening</h3>
                        <p><strong>Goal:</strong> Eradicate adenomas before malignant transformation.</p>
                        <ul class="enhanced-list">
                            <li><strong>High-risk screening:</strong> For family history of FAP/HNPCC, personal history of polyps/cancer/IBD.</li>
                            <li><strong>Methods:</strong> Colonoscopy, Double-contrast barium enema, FOBT + Sigmoidoscopy.</li>
                        </ul>

                        <h3>Prognosis</h3>
                        <p><strong>5-Year Survival:</strong> Stage I (72%), Stage II (54%), Stage III (39%), Stage IV (7%).</p>
                        <p><strong>Poor prognostic factors:</strong> Pre-op high CEA (>5ng/mL), bowel wall penetration, adherence to organs, perforation, nodal involvement, venous invasion, poor differentiation, aneuploidy, chromosome 18q loss.</p>
                    </div>
                </section>
                <!-- END: management -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="12-cleft-lip-and-palate.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 21.6%;"></div>
                        </div>
                       <span class="progress-text">Topic 13 of 60</span>
                    </div>
                    <a href="14-pyloric-stenosis.html" class="nav-button">
                        <span class="nav-text">Next: Pyloric Stenosis</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>